Search

New research led by Kip Connor, PhD, finds that microglia—the primary immune cells of the central nervous system, including the retina—play a vital role in regulating neuroinflammation in autoimmune uveitis. The study, published in Proceedings of the National Academy of Sciences and featured on...

The Department of Ophthalmology was well represented at this year’s Association for Research and Vision in Ophthalmology (ARVO) Annual Meeting, held April 22 through May 2 in Vancouver, British Columbia. More than 160 faculty and trainees participated as course instructors, panelists, lecturers and...

Thirty-two Harvard Ophthalmology/Mass. Eye and Ear clinical trainees graduated on Thursday, June 20th. The ceremony celebrated eight Harvard Ophthalmology residents, the AY 2018–2019 Chief Resident and one optometry resident, as well as 22 clinical fellows from Mass. Eye and Ear, Joslin Diabetes...

Second-year Harvard Ophthalmology resident Noam Rudnick, MD, PhD, received the 2019 Gragoudas-Folkman Award, which will provide up to $20,000 to help fund his research on cell type-specific roles of autophagy in age-related macular degeneration. He will complete the project under the guidance of his...

On July 1, Partners launched a new, mobile-based system to track attendance and CME credit for Ophthalmology Grand Rounds and the Retina Service Conference. Here’s how it works: Log in to Your Account Visit the Partners Office of Continuing Professional Development If you are a Partners employee...

The Tej Kohli Foundation has pledged $2 million over five years to establish the Tej Kohli Cornea Program at Mass. Eye and Ear, which will accelerate innovative and collaborative research to achieve unprecedented breakthroughs in corneal disease. “We are really excited to embark on this partnership...

Ye Sun, MD, PhD (Boston Children's Hospital)National Eye Institute: $2,210,000 over five yearsPhotoreceptor determination of retinal blood vessel growth in retinopathy Joseph Ciolino, MD (Mass. Eye and Ear)US Army Medical Research Acquisition Activity: $2,098,767 over three yearsSteroid-eluting...

OCU400, a novel gene therapy platform developed by Neena Haider, PhD, Harvard Medical School Associate Professor of Ophthalmology and Associate Scientist at the Schepens Eye Research Institute of Mass. Eye and Ear, and licensed to biopharmaceutical company Ocugen, Inc., has been granted orphan drug...